Clinical Trial Update: Bortezomib, Cyclophosphamide, Dexamethasone, and Thalidomide in Treating Patients With Newly Diagnosed, Previously Untreated Multiple Myeloma [Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 2 study evaluating a four-drug regimen (bortezomib, cyclophosphamide, dexamethasone, and thalidomide) in patients w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Cytoxan (cyclophosphamide)
• Decadron (Dexamethasone)
• Thalomid (thalidomide)
• Velcade (bortezomib)

Snippet

Sponsor: Fred Hutchinson Cancer Center | Conditions: Multiple Myeloma and Plasma Cell Neoplasm | Phase 2 | Status: UNKNOWN